MXPA04003354A - Derivados de acido [[2-(amino-3,4-dioxo-1-ciclobuten-1-il)amino]alquilico] para tratamiento de dolor. - Google Patents

Derivados de acido [[2-(amino-3,4-dioxo-1-ciclobuten-1-il)amino]alquilico] para tratamiento de dolor.

Info

Publication number
MXPA04003354A
MXPA04003354A MXPA04003354A MXPA04003354A MXPA04003354A MX PA04003354 A MXPA04003354 A MX PA04003354A MX PA04003354 A MXPA04003354 A MX PA04003354A MX PA04003354 A MXPA04003354 A MX PA04003354A MX PA04003354 A MXPA04003354 A MX PA04003354A
Authority
MX
Mexico
Prior art keywords
alkyl
amino
pain
dioxo
treatment
Prior art date
Application number
MXPA04003354A
Other languages
English (en)
Inventor
Maria Zaleska Margaret
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA04003354A publication Critical patent/MXPA04003354A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invencion proporciona un metodo para tratar el dolor en un mamifero que incluye administrar a un mamifero en necesidad de tal tratamiento una cantidad efectiva para tratar el dolor de un compuesto de la formula (I): donde R1 es H, alquilo o fenilalquilo; R2 es H, alquilo, alquenilo o fenilalquilo; o R1 y R2, tomados conjuntamente como Z, son -CH2CH2-, -CH2C(R6)(R7)CH2- o -CH2C(R8)(R9)-C(R10)(R11)CH2-, donde R6, R8 y R10 son, independientemente, H, alquilo o hidroxilo y R7, R9 R11 son, independientemente, H, o alquilo; A es alquileno o alquenileno; X es CO2R3, P(O)(OR4)(OR5), 3,5 dioxo-1,2,4-oxadiazolidin-2-ilo o 5-tetrazolilo, en los cuales R3, R4 y R5 son, independientemente, H o alquilo; o composiciones farmaceuticas para tratar el dolor que contienen una cantidad efectiva para tratar el dolor del compuesto de la formula (I).
MXPA04003354A 2001-10-10 2002-10-09 Derivados de acido [[2-(amino-3,4-dioxo-1-ciclobuten-1-il)amino]alquilico] para tratamiento de dolor. MXPA04003354A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32824501P 2001-10-10 2001-10-10
PCT/US2002/032252 WO2003031416A2 (en) 2001-10-10 2002-10-09 [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain

Publications (1)

Publication Number Publication Date
MXPA04003354A true MXPA04003354A (es) 2004-09-28

Family

ID=23280159

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003354A MXPA04003354A (es) 2001-10-10 2002-10-09 Derivados de acido [[2-(amino-3,4-dioxo-1-ciclobuten-1-il)amino]alquilico] para tratamiento de dolor.

Country Status (27)

Country Link
US (2) US7098200B2 (es)
EP (1) EP1434588B1 (es)
JP (1) JP4350512B2 (es)
KR (1) KR100922703B1 (es)
CN (1) CN100448449C (es)
AR (1) AR036764A1 (es)
AT (1) ATE515266T1 (es)
AU (1) AU2009201746A1 (es)
BR (1) BR0213237A (es)
CA (1) CA2461348C (es)
CY (1) CY1111909T1 (es)
DK (1) DK1434588T3 (es)
EA (1) EA009993B1 (es)
ES (1) ES2367356T3 (es)
HK (1) HK1064609A1 (es)
HU (1) HUP0401773A3 (es)
IL (2) IL161275A0 (es)
MX (1) MXPA04003354A (es)
NO (1) NO20041378L (es)
NZ (1) NZ532159A (es)
PL (1) PL368863A1 (es)
PT (1) PT1434588E (es)
SI (1) SI1434588T1 (es)
TW (1) TWI321472B (es)
UA (1) UA78529C2 (es)
WO (1) WO2003031416A2 (es)
ZA (1) ZA200403406B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2819854T3 (es) 2002-11-22 2021-04-19 Gruenenthal Gmbh Uso de (1R,2R)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol para tratar el dolor inflamatorio
PL1611144T3 (pl) * 2003-04-09 2011-03-31 Wyeth Llc Pochodne kwasu 2-(8,9-diokso-2,6-diazabicyklo(5.2.0)non-1(7)-en-2-ylo)alkilofosfonowego i ich zastosowanie jako antagonistów receptora N-metylo-D-asparaginianu (NMDA)
AU2004229567A1 (en) * 2003-04-09 2004-10-28 Wyeth Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof
US20050142192A1 (en) * 2003-10-15 2005-06-30 Wyeth Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
TW200514775A (en) * 2003-10-22 2005-05-01 Wyeth Corp Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
DE602005017915D1 (de) * 2004-10-08 2010-01-07 Wyeth Corp Derivate von ä2-(8,9-dioxo-2,6-diazabicycloä5.2.0ünon-1(7)-en-2-yl)alkylüphosphonsäure und verfahren zu deren herstellung
WO2009029618A1 (en) * 2007-08-27 2009-03-05 Wyeth Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
ES2733905T3 (es) * 2009-02-13 2019-12-03 Allergan Inc Composiciones farmacéuticas que comprenden (3-(1-(1H-imidazol-4-il)etil)-2-metilfenil)metanol
AR075900A1 (es) 2009-03-19 2011-05-04 Wyeth Llc Metodos para la preparacion de acidos (2-(8,9-dioxo-2,6-diazabiciclico (5.2.0) non-1(7)-en-2-il)etil) fosfonico y sus precursores.
WO2013078151A1 (en) 2011-11-21 2013-05-30 Allergan, Inc. Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases
US10292989B2 (en) 2014-03-28 2019-05-21 University Of Virginia Patent Foundation General anesthetics that are not neurotoxic

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5168103A (en) 1991-01-22 1992-12-01 American Home Products Corporation [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
US5124319A (en) 1991-10-11 1992-06-23 American Home Products Corporation Benzimidazole phosphono-amino acids
DK124393D0 (da) 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
AT400440B (de) * 1993-12-06 1995-12-27 Vianova Kunstharz Ag Verfahren zur herstellung von wasserverdünnbaren lackbindemitteln und deren verwendung
TW427904B (en) * 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
UA52698C2 (uk) * 1996-10-04 2003-01-15 Х. Луннбек А/С Похідні (3-алкоксіізоксазол-4-іл)заміщеної 2-амінокарбонової кислоти та їх сірковмісні аналоги, фармацевтична композиція на їх основі
US5990307A (en) 1997-08-01 1999-11-23 American Home Products Corporation Process for the preparation of [2-((8.9)-Dioxo-2,6-Diazabicyclo [5.2.0]-Non-1(7)-en-2yl) Ethyl]Phosphonic acid
WO1999006417A1 (en) 1997-08-01 1999-02-11 American Home Products Corporation Process for the preparation of [2-((8,9)- dioxo-2,6-diazabicyclo [5.2.0]-non-1(7)-en-2-yl)-ethyl] phosphonic acid
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
US6225343B1 (en) 1999-06-16 2001-05-01 Nastech Pharmaceutical Company, Inc. Compositions and methods comprising morphine gluconate
US20030158254A1 (en) 2002-01-24 2003-08-21 Xenoport, Inc. Engineering absorption of therapeutic compounds via colonic transporters
US20040082543A1 (en) 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain

Also Published As

Publication number Publication date
KR100922703B1 (ko) 2009-10-22
DK1434588T3 (da) 2011-08-15
US20030114444A1 (en) 2003-06-19
US7098200B2 (en) 2006-08-29
CN1568189A (zh) 2005-01-19
PL368863A1 (en) 2005-04-04
US7759346B2 (en) 2010-07-20
EP1434588A2 (en) 2004-07-07
UA78529C2 (en) 2007-04-10
PT1434588E (pt) 2011-09-05
CY1111909T1 (el) 2015-11-04
AR036764A1 (es) 2004-09-29
JP2005508950A (ja) 2005-04-07
EA200400523A1 (ru) 2004-08-26
KR20050034604A (ko) 2005-04-14
NO20041378L (no) 2004-05-28
HK1064609A1 (en) 2005-02-04
HUP0401773A3 (en) 2005-06-28
IL161275A0 (en) 2004-09-27
ES2367356T3 (es) 2011-11-02
AU2009201746A1 (en) 2009-05-28
CA2461348A1 (en) 2003-04-17
SI1434588T1 (sl) 2011-10-28
TWI321472B (en) 2010-03-11
US20060205696A1 (en) 2006-09-14
BR0213237A (pt) 2004-09-28
WO2003031416A3 (en) 2003-08-14
NZ532159A (en) 2006-02-24
CA2461348C (en) 2011-02-15
ATE515266T1 (de) 2011-07-15
ZA200403406B (en) 2007-04-25
EA009993B1 (ru) 2008-06-30
IL161275A (en) 2009-09-01
JP4350512B2 (ja) 2009-10-21
CN100448449C (zh) 2009-01-07
EP1434588B1 (en) 2011-07-06
HUP0401773A2 (hu) 2005-01-28
WO2003031416A2 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
CY1111909T1 (el) Παραγωγα [[2-(αμινο-3,4-διοξο-1-κυκλοβουτεν-1-υλ)amino] αλκυλ]-οξεος για τη θεραπεια του πονου
DE69514813D1 (en) Bicyclische diarylheterocyclen als cyclooxygenase-2-inhibitoren
HK1091481A1 (en) Therapeutic agents useful for treating pain
WO2001081312A3 (en) Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
DE69529690T2 (de) Diaryl-2(5h)-fuaranone als cox-2-inhibitoren
UA70958C2 (uk) Спосіб лікування захворювання, пов'язаного з порушенням метаболізму естрогену (варіанти)
AP1541A (en) New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors.
TWI265929B (en) Triazinyl derivatives for inhibiting the production of IL-12
DE60011589D1 (de) Hochwirksame dihydroergotaminhaltige arzneizusammensetzungen
RU94036772A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
TW427887B (en) Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections
IL162614A0 (en) Liposomal delivery of vitamin e based compounds
FR2705343B1 (fr) Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique.
DE69825154D1 (de) Pyridazinone als inhibitoren von cyclooxygenase-2
MXPA02001571A (es) Metodo de tratamiento para el cancer.
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
IL148196A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
AU2368802A (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
GB0504362D0 (en) Cytokine modulators
DE69829861D1 (de) 2-aminopyridine als inhibitoren von cyclooxygenase-2
DK0570245T3 (da) Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
MXPA02011966A (es) Derivados de higromicina a para el el tratamiento de infecciones bacterianas y por protozoarios.
GR3035010T3 (en) New derivatives of glycylanilides, preparation and therapeutical application
ES2075798A1 (es) Derivados de aminoacidos naturales como inhibidores de metaloproteinasas, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de dichos compuestos en medicina.

Legal Events

Date Code Title Description
FG Grant or registration